Exane Derivatives’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Exane Derivatives’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-138	Closed	-$29.9K	–	1094
2021 Q1	$29.9K	Sell	138 -38	-22%	-$7.14K	0.01%	545
2020 Q4	$20.3K	Sell	176 -36	-17%	-$4.03K	0.01%	508
2020 Q3	$20.6K	Hold	212	–	–	0.01%	438
2020 Q2	$26K	Sell	212 -65	-23%	-$7.37K	0.01%	387
2020 Q1	$24.3K	Hold	277	–	–	0.01%	402
2019 Q4	$32.4K	Sell	277 -1,185	-81%	-$133K	0.01%	377
2019 Q3	$168K	Sell	1,462 -221	-13%	-$33.5K	0.03%	270
2019 Q2	$290K	Buy	1,683 +1,515	+902%	+$262K	0.05%	224
2019 Q1	$28.3K	Buy	+168	New	+$25K	0.01%	362

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Exane Derivatives's GWPH Position: Q2 2021 in Review

Exane Derivatives sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 138 shares — an estimated $29.9K sold.

Exane Derivatives first reported a position in GWPH in Q1 2019 and held it in 9 quarters. The position peaked at $290K in Q2 2019. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Exane Derivatives reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Exane Derivatives sold 138 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $29.9K.
Exane Derivatives first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2019 and held it in 9 quarters.
Exane Derivatives's GW Pharmaceuticals Plc American Depositary Shares position peaked at $290K in Q2 2019.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Exane Derivatives's 13F filing for Q2 2021, filed 28 Jul 2021.